Subtotal $0.00
Shop Now
Wegovy vs Ozempic is really a comparison of two brands of the same drug. Both contain semaglutide, a GLP-1 receptor agonist made by Novo Nordisk. The difference is what each one is approved for: Ozempic is a type 2 diabetes medicine, while Wegovy is approved for long-term weight management, for lowering cardiovascular risk in adults with heart disease and obesity or overweight, and for a form of fatty liver disease. They also come in different strengths and devices, and each brand now has a daily pill. This guide compares Ozempic vs Wegovy using the current U.S. labels.
Peptide Labs does not sell Wegovy, Ozempic or any prescription drug. This article is general information, not medical advice. Which product, if any, suits a person is a decision for a licensed prescriber.
Key Takeaways
- Wegovy and Ozempic contain the same active ingredient, semaglutide.
- Ozempic is approved for type 2 diabetes; Wegovy is approved for weight management and cardiovascular risk.
- Wegovy injections go up to higher weekly strengths than Ozempic.
- Both brands have tablets: Ozempic tablets for diabetes and Wegovy tablets for weight management.
- The labels say not to use two semaglutide products, or two GLP-1 drugs, together.
Wegovy vs Ozempic at a glance
The table summarizes the injections, which are the versions most people mean. Strengths are listed only to show how the products differ; a prescriber sets the dose.
| Ozempic (injection) | Wegovy (injection) | |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| First FDA approval | December 2017 | June 2021 |
| Main approved use | Blood sugar control in adults with type 2 diabetes | Long-term weight management in adults and children 12 and older |
| Other approved uses | Lowering heart attack, stroke and CV death risk in type 2 diabetes with heart disease; lowering kidney and CV risk in type 2 diabetes with chronic kidney disease | Lowering heart attack, stroke and CV death risk in adults with heart disease and obesity or overweight; MASH liver disease with moderate to advanced fibrosis |
| Needs type 2 diabetes? | Yes | No |
| Weekly strengths on the label | 0.25, 0.5, 1 and 2 mg | 0.25, 0.5, 1, 1.7, 2.4 and 7.2 mg |
| Devices | Multi-dose pens; single-dose prefilled syringe | Single-dose pens; single-dose syringes; multi-dose FlexTouch pen |
| Pill version | Ozempic tablets (type 2 diabetes) | Wegovy tablets (weight management) |
| Boxed warning | Thyroid C-cell tumors | Thyroid C-cell tumors |
Is Wegovy the same as Ozempic?
Chemically, yes: the semaglutide in both is the same molecule. What differs is the regulatory package around it. Each brand went through its own clinical trials and FDA review for specific uses, and a product is only FDA-approved for the indications on its own label. Ozempic was studied for blood sugar control in the SUSTAIN trials, then for cardiovascular and kidney outcomes. Wegovy was studied at higher doses in the STEP weight-management trials, then in SELECT, a cardiovascular outcomes trial in people with heart disease and excess weight but without diabetes. For background on the molecule, see our semaglutide profile.
That is also why they are not swapped freely. Using Ozempic for weight loss in someone without diabetes is off-label, and the Wegovy label states that it should not be combined with other semaglutide-containing products or any other GLP-1 receptor agonist.
Approved uses: diabetes vs weight management
Ozempic
According to its prescribing information, revised in May 2026, Ozempic is approved alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes. It is also approved to lower the risk of major cardiovascular events in adults with type 2 diabetes and established heart disease, and, since January 2025, to lower the risk of kidney function decline, kidney failure and cardiovascular death in adults with type 2 diabetes and chronic kidney disease. It is not approved for weight management or for children.
Wegovy
The Wegovy label, revised in June 2026, approves the injection with a reduced-calorie diet and more physical activity to reduce excess weight and keep it off long term in adults with obesity, adults with overweight and at least one weight-related condition, and children 12 and older with obesity. It is also approved to lower the risk of heart attack, stroke and cardiovascular death in adults with heart disease and obesity or overweight (added March 2024), and, under accelerated approval since August 2025, for noncirrhotic MASH with moderate to advanced liver fibrosis.
Strengths and devices
Wegovy reaches higher weekly strengths than Ozempic because weight management in trials used higher doses than diabetes care. The 2026 Wegovy label includes a 7.2 mg strength, sold as Wegovy HD, as well as the long-standing 2.4 mg maintenance strength. Ozempic tops out at 2 mg. Both start low and are increased gradually to limit digestive side effects; the schedule belongs to the prescriber.
Devices differ too. Ozempic comes in multi-dose pens that deliver several weekly doses, and its May 2026 label also lists a single-dose prefilled syringe. Wegovy comes in single-dose pens, single-dose syringes with a built-in needle and a multi-dose FlexTouch pen. The labels warn that pens must never be shared between people, even with a new needle.
The pill forms: Ozempic tablets and Wegovy tablets
Both brands now have a once-daily tablet, which adds another layer of naming:
- Ozempic tablets are a newer oral semaglutide formulation for type 2 diabetes. The FDA approved the Ozempic name for them on February 4, 2026, and Novo Nordisk made them available in May 2026. They share a label with Rybelsus, the original semaglutide tablet from 2019, which is being phased out. The two are not interchangeable milligram for milligram.
- Wegovy tablets, the Wegovy pill, were approved on December 22, 2025, for weight management and cardiovascular risk reduction in adults, and reached pharmacies in January 2026.
All oral semaglutide products come with empty-stomach instructions: the tablet is taken in the morning with a small amount of plain water, before food, drink or other medicines. A pharmacist can explain the details. Our Ozempic pill guide and Wegovy pill guide cover each tablet.
Ozempic vs Wegovy side effects
Because both are semaglutide, their side effects and warnings are the same in kind. Nausea, diarrhea, vomiting, constipation and stomach pain are the most common, mostly while the dose is being increased. Both labels carry a boxed warning about thyroid C-cell tumors seen in rodents and warn about pancreatitis, gallbladder disease, kidney injury from dehydration and diabetic eye complications. Side effects were reported more often in the Wegovy weight trials than in Ozempic’s diabetes trials: nausea affected 44% of adults on Wegovy injection versus 16% on placebo, compared with about 16% to 20% on Ozempic. These trials enrolled different people, so the figures cannot be compared directly. The Wegovy label no longer carries a suicidal-thoughts warning after the FDA requested its removal in January 2026. See our full guide to semaglutide side effects.
Coverage and cost: the general picture
Insurance often handles the two brands differently because of their approved uses. Plans that cover diabetes medicines may cover Ozempic for type 2 diabetes, while coverage for weight-management drugs such as Wegovy varies widely between plans and has changed repeatedly in recent years. Some plans require prior authorization. Your plan’s formulary, your pharmacist or your prescriber’s office can tell you what applies to you. If you are comparing semaglutide with tirzepatide, read semaglutide vs tirzepatide, and for tirzepatide’s own two brands, Mounjaro vs Zepbound.
Frequently Asked Questions
Is Wegovy stronger than Ozempic?
Wegovy injections go up to higher weekly strengths, 2.4 mg and 7.2 mg, than Ozempic’s 2 mg maximum. The drug is the same; the approved strengths differ because Wegovy is approved for weight management.
Can Ozempic be used for weight loss?
Ozempic is FDA-approved for type 2 diabetes, not weight management. Wegovy is the semaglutide brand approved for weight management. Using Ozempic for weight loss alone is off-label.
Are Wegovy and Ozempic the same drug?
Both contain semaglutide, but they are approved for different uses, in different strengths and devices, and are not interchangeable without a prescriber’s decision.
Do Wegovy and Ozempic have the same side effects?
Yes, in kind: mainly nausea, diarrhea, vomiting and constipation, plus the same boxed warning. Rates were higher in Wegovy’s weight trials, which used higher doses.
Is there a pill version of Wegovy or Ozempic?
Yes. Wegovy tablets were approved in December 2025 for weight management, and Ozempic tablets, a newer semaglutide tablet for type 2 diabetes, received the Ozempic name in February 2026.
Can you take Wegovy and Ozempic together?
No. The labels say semaglutide products should not be combined with each other or with other GLP-1 receptor agonists.
This article is general information, not medical advice. Peptide Labs does not sell prescription drugs, including any product named here. Read the Medication Guide that comes with a prescription, and ask a pharmacist or prescriber how this information applies to you.
Last reviewed September 2026.
Related guides: Ozempic Alternatives: FDA-Approved Options, OTC Facts and What to Avoid, Liraglutide vs Semaglutide: Daily vs Weekly GLP-1 Drugs Compared, Wegovy Side Effects: Injection, Pill, Teens and Wegovy HD, Trulicity vs Ozempic: Dulaglutide and Semaglutide Compared, How Long Does Ozempic Take to Work? Labels and Trials Explained, Is Semaglutide the Same as Ozempic? Brands and Forms Explained.